Form 8-K CURIS INC For: Nov 10

Go back to Form 8-K CURIS INC For: Nov 10

Roth Affirms Curis (CRIS) at 'Buy' Following Q3 Report, Update; Pipeline Progress is Encouraging

November 10, 2014 2:34 PM EST

Roth Capital reaffirms its Buy rating and $10 price target on Curis (Nasdaq: CRIS) following Q3 results reported earlier Monday.

Analyst Joseph Pantginis noted that Curis' Q3 loss of $0.06 per share compared with the firm's loss estimate of $0.05 per share.

Pantginis noted: While we had expected to see... More